Skip to main content
SpringerLink
Log in

Review: Copper and inflammation — a possible rationale for the pharmalogical manipulation of inflammatory discorders

  • Immunosuppression and Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Acute and chronic inflammations are characterized, among other features, by changes in the metabolism of copper and by a widespread responsiveness to the therapy with copper-containing molecules.

The exact map of inflammation-induced copper movements as well as the role played by the metal in the pathogenesis of inflammatory disorders are, however, far from being clear, and this is especially true in the case of chronic processes.

Nevertheless the present knowledge suggests that the ‘copper approach’ may provide a new way for coping with the problem of anti-inflammatory/anti-arthritic therapies. The administration of exogenous copper, and thein vivo manipulation of the endogenous metal levels are proposed as two possible therapeutic strategies, not necessarily mutually exclusive.

For a better understanding of the value of such an approach, further research work is needed, especially to attain a more detailed know-how on the involved chemical forms, distribution and functions of copper in both normal as well as inflamed organisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M.W. Whitehouse,Ambivalent role of copper in inflammatory disorders, Agents and Actions6, 201–205 (1976).

    PubMed  Google Scholar 

  2. I.L. Bonta, Endogenous substances as modulators of inflammation. InInflammation: Mechanisms and their Impact on Therapy, pp. 121–131 (EdsI.L. Bonta, J. Thompson andK. Brune). Birkhäuser, Basel 1977.

    Google Scholar 

  3. J.R.J. Sorenson,Evaluation of copper complexes as potential anti-arthritic drugs, J. Pharm. Pharmac.29, 450–452 (1977).

    Google Scholar 

  4. R. Milanino, E. Passarella andG.P. Velo, Copper and the inflammatory process. InAdvances in Inflammation Research, vol. 1, pp. 281–291 (EdsG. Weissmann, B. Samuelsson andR. Paoletti). Raven Press, New York 1979.

    Google Scholar 

  5. J.R.J. Sorenson, Copper complexes. A unique class of anti-arthritic drugs. InProgress in Medicinal Chemistry, vol. 15, pp. 211–260 (EdsG.P. Ellis andG.B. West). Elsevier/North-Holland 1978.

  6. A.J. Lewis, W.E. Smith andD.H. Brown, A comparison of the anti-inflammatory activities of copper complexes in different models of inflammation, InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 327–338 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  7. E.J. Lewis andG.B. West, Copper complexes and experimentally-induced inflammation and arthritis. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 339–358 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  8. K.D. Rainsford, Development and therapeutic actions of oral copper complexes of anti-inflammatory drugs. InInflammatory Diesease and Copper, pp. 375–384 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  9. M.W. Whitehouse andW.R. Walker,Copper and inflammation. Agents and Actions8, 85–90 (1978).

    PubMed  Google Scholar 

  10. W.R. Walker andKeats,An investigation of the therapeutic value of the ‘copper bracelet’. Dermal assimilation of copper in arthritic/rheumatoid conditions, Agents and Actions6, 454–459 (1976).

    PubMed  Google Scholar 

  11. W.R. Walker, The results of a copper bracelet clinical trial and subsequent studies. InInflammatory Diseases and Copper, pp. 469–478 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  12. R. Milanino, E. Passarella andG.P. Velo,Adjuvant arthritis in young copper-deficient rats, Agents and Actions8, 623–628 (1978).

    PubMed  Google Scholar 

  13. G.B. West,Diet and adjuvant-induced arthritis in the rat, Int. Archs. Allergy appl. Immun.63, 347–350 (1980).

    Google Scholar 

  14. R. Milanino, S. Mazzoli, E. Passarella, G. Tarter andG.P. Velo,Carrageenan oedema in copper-deficient rats, Agents and Actions8, 618–622 (1978).

    PubMed  Google Scholar 

  15. V. Kishore, N. Latman, D.W. Roberts, J.B. Barnett andJ.R.J. Sorenson,Effects of nutritional copper deficiency on adjuvant arthritis and immunocompetence in the rat, Agents and Actions14, 274–282 (1984).

    Article  PubMed  Google Scholar 

  16. K.D. Rainsford, Environmental metal ion perturbations, especially as they affect copper status, are factors in the etiology of arthritic conditions: an hypothesis. InInflammatory Diseases and Copper, pp. 137–142 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  17. J.R.J. Sorenson, Personal Communication (1983).

  18. M.C. Powanda, The role of leukocytes endogenous mediator (endogenous pyrogen) in inflammation. InInflammatory Diseases and Copper, pp. 31–40 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  19. L.M. Klevay, An appraisal of current human copper nutrition. InInflammatory Diseases and Copper, pp. 123–132 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  20. A. Lorber, L.S. Cutler andC.C. Chang,Serum copper levels in rheumatoid arthritis: relationship of elevated copper to protein alterations, Arthritis Rheum.11, 65–71 (1968).

    PubMed  Google Scholar 

  21. D.P. Bajpayee,Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis, Ann. rheum. Dis.34, 162–165 (1975).

    PubMed  Google Scholar 

  22. J.R.J. Sorenson andD. DiTommaso,Correspondence, Ann. rheum. Dis.35, 186–188 (1976).

    PubMed  Google Scholar 

  23. C.W. Denko andP. Gabriel, Serum proteins-transferrin, ceruloplasmin, albumin, α1-acid glycoprotein, α1-antitrypsin — in rheumatic disorders, J. Rheum.6, 664–672 (1979).

    PubMed  Google Scholar 

  24. P.R. Scudder, D. Al-Timini, W. McMurray, A.G. White, B.C. Zoob andT.L. Dormandy,Serum copper and related variables in rheumatoid arthritis, Ann. rheum. Dis.37, 67–70 (1978).

    PubMed  Google Scholar 

  25. D.H. Brown, N.W. Buchanan, A.F. El-Ghobarey, W.E. Smith andJ. Teape,Serum copper and its relationship to clinical symptoms in rheumatoid arthritis, Ann. rheum. Dis.38, 174–176 (1979).

    PubMed  Google Scholar 

  26. A. Conforti, L. Franco, G. Menegale, R. Milanino, G. Piemonte andG.P. Velo,Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implications, Pharmacol. Res. Commun.15, 859–867 (1983).

    PubMed  Google Scholar 

  27. P.R. Scudder, W. McMurray, A.G. White andT.L. Dormandy,Synovial fluid copper and related variables in rheumatoid and degenerative arthritis, Ann. rheum. Dis.37, 71–72 (1978).

    PubMed  Google Scholar 

  28. J. Lunec, D.G. Wickens, T.L. Graff andT.L. Dormandy, Copper, free radicals and rheumatoid arthritis. InInflammatory Diseases and Copper, pp. 231–240 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  29. R. Milanino andG.P. Velo, Multiple actions of copper in control of inflammation: studies in copperdificient rats. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 209–230 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  30. D.S. Karabelas,Copper metabolism in the adjuvantinduced arthritic rat. Univ. Microfilms Ann Arbor, Mich., Order No. 72-31,092. From Diss. Abstr. Int. B 1972-33 (6), 2776 (1972).

    Google Scholar 

  31. D.R. Williams, C. Furnival andP.M. May, computer analysis of low molecular weight copper complexes in biofluids. InInflammatory Diseases and Copper, pp. 45–56 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  32. B.F. Feldman, C.L. Keen, J.J. Kaneko andT.B. Farver,Anemia of inflammatory disease in the dog: measurement of hepatic superoxide dismutase, hepatic nonheme iron, copper, zinc, and ceruloplasmin and serum iron, copper, and zinc, Am. J. Vet. Res.42, 1114–1117 (1981).

    PubMed  Google Scholar 

  33. A. Conforti, L. Franco, R. Milanino, A. Totorizzo andG.P. Velo,Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats, Br. J. Pharmac.79, 45–52 (1983).

    Google Scholar 

  34. G.P. Velo, L. Franco, A. Conforti andR. Milanino, Copper and inflammation. InInflammatory Diseases and Copper, pp. 329–342 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  35. D.J. Al-Timini andT.L. Dormandy,The inhibition of lipid autoxidation by human ceruloplasmin, Biochem. J.168, 283–288 (1977).

    PubMed  Google Scholar 

  36. S.C. Sweeney,Alterations in tissue and serum ceruloplasmin concentration associated with inflammation, J. Dental Res.46, 1171–1176 (1967).

    Google Scholar 

  37. U. Weser andL.M. Schubotz, Catalytic reaction of copper complexes with superoxide. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 103–120 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  38. J.M. McCord, Roles of superoxide in inflammation and ischemic shock. InInflammatory Diseases and Copper, pp. 255–262 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  39. W. Huber, K.B. Menander-Huber, M.G.P. Saifer andP.H.-C. Dang, Studies on the clinical and laboratory pharmacology of drug formulations of bovine Cu−Zn superoxide dismutases (orgotein). InPerspectives in Inflammation, pp. 527–540 (EdsD.A. Willoughby, J.P. Giroud andG.P. Velo). MTP Press, Lancaster 1977.

    Google Scholar 

  40. M. Rister, Superoxide anion and superoxide dismutase activity in arthritic conditions. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 137–143 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  41. J.C. Banford, D.H. Brown, R.A. Hazelton, C.J. McNeil, R.D. Sturrock andW.E. Smith,Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis, Ann. rheum. Dis.41, 458–462 (1982).

    PubMed  Google Scholar 

  42. I.L. Bonta, P.C. Bragt andP. Muus, Hepatic adaptation process during inflammatory conditions: role of trace elements, lipid peroxidation and ceruloplasmin. InInflammatory Diseases and Copper, pp. 243–252 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  43. A.J. Lewis,A comparison of the anti-inflammatory effects of copper aspirinate and other copper salts in the rat and guinea pig, Agents and Actions8, 244–250 (1978).

    Article  PubMed  Google Scholar 

  44. J.R.J. Sorenson,Copper chelates as possible active forms of the antiarthritic agents, J. Med. Chem.19, 135–148 (1976).

    Article  PubMed  Google Scholar 

  45. G.E. Jackson, P.M. May andD.R. Williams,Metal-ligang complexes involved in rheumatoid arthritis. I. Justification for copper administration, J. inorg. nucl. Chem.40, 1189–1194 (1978).

    Article  Google Scholar 

  46. D.H. Brown, W.E. Smith, J.W. Teape andA.J. Lewis,Anti-inflammatory effect of some copper complexes, J. Med. Chem.23, 729–734 (1980).

    Article  PubMed  Google Scholar 

  47. J.M. McCord, S.M. Stokes andK. Wong, Superoxide radical as a phagocyte-produced chemical mediator of inflammation. InAdvances in Inflammation Research, Vol. 1, pp. 273–280 (EdsG. Weissmann, B. Samuelsson andR. Paoletti). Raven Press, New York 1979.

    Google Scholar 

  48. F.M. Veronese, E. Boccu', O. Schiavon, G.P. Velo, A. Conforti, L. Franco andR. Milanino,Antiinflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters, J. Pharm. Pharmac.35, 757–758 (1983).

    Google Scholar 

  49. C.W. Denko,Protective role of ceruloplasmin in inflammation, Agents and Actions9, 333–336 (1979).

    PubMed  Google Scholar 

  50. M.J. Laroche, P. Chappuis, Y. Henry andF. Rousselet, Ceruloplasmin: experimental anti-inflammatory activity and physicochemical properties. InInflammatory Diseases and Copper, pp. 61–70 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  51. H.M.A. Dollwet, S.P. Schmidt andR.E. Seeman,Anti-inflammatory properties of copper inplants in the rat paw edema: a preliminary study, Agents and Actions11, 746–749 (1981).

    Article  PubMed  Google Scholar 

  52. K.D. Rainsford andM.W. Whitehouse,Concerning the merits of copper aspirin as a potential antiinflammatory drug, J. Pharm. Pharmac.28, 83–86 (1976).

    Google Scholar 

  53. R. Milanino, A. Conforti, M.E. Fracasso, L. Franco, R. Leone, E. Passarella, G. Tarter andG.P. Velo,Concerning the role of endogenous copper in the acute inflammatory process, Agents and Actions9, 581–588 (1979).

    PubMed  Google Scholar 

  54. C.W. Denko, M. Petricevic andM.W. Whitehouse,Inflammation in relation to dietary intake of zinc and copper, Int. J. Tiss. React.3, 73–76 (1981).

    Google Scholar 

  55. A. Conforti, L. Franco, R. Milanino andG.P. Velo,Copper and ceruloplasmin (Cp) concentrations during the acute inflammatory process in the rat, Agents and Actions12, 303–307 (1982).

    Article  PubMed  Google Scholar 

  56. V. Albergoni, A. Cassini, N. Favero andG.P. Rocco,Effect of penicillamine on some metals and metalloproteins in the rat, Biochem. Pharmac.24, 1131–1133 (1975).

    Article  Google Scholar 

  57. V. Albergoni, N. Favero andG.P. Rocco,Copper metabolism in the rat: effects of copper loading and copper depletion, Bioinorg. Chem.9, 431–440 (1978).

    Article  Google Scholar 

  58. R. Milanino, L. Franco, A. Conforti, M. Marrella andG.P. Velo,Copper metabolism in acute inflammatory process and its possible significance for a novel approach to the therapy of inflammation. Abstract. 1st World Conference on Inflammation, Venice, April 16–18 (1984).

  59. G.W. Evans andW.T. Johnson, Copper homeostasis. InInflammatory Diseases and Copper, pp. 3–13 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  60. E.J. Underwood Trace Elements in Human and Animal Nutrition, 4th ed., pp. 56–108. Academic Press, New York 1977.

    Google Scholar 

  61. J.R.J. Sorenson, Development of copper complexes for potential therapeutic use. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 305–325 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  62. W. Hangarter, Copper-salicylate in rheumatoid arthritis and similar degenerative diseases. InInflammatory Diseases and Copper, pp. 439–449 (Ed.J.R.J. Sorenson). Humana Press, Clifton 1982.

    Google Scholar 

  63. D.D. Perrin andM.W. Whitehouse, Metal ion therapy: some fundamental consideration. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 261–290 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  64. W.R. Walker, S.J. Beveridge andM.W. Whitehouse, Dermal copper drugs: the copper bracelet and Cu(II) salicylate complexes. InTrace Elements in the Pathogenesis and Treatment of Inflammation, pp. 359–367 (EdsK.D. Rainsford, K. Brune andM.W. Whitehouse). Birkhäuser, Basel 1981.

    Google Scholar 

  65. S.J. Beveridge, M.W. Whitehouse andW.R. Walker,Lipophilic copper(II) formulations: some correlation between their composition and anti-inflammatory/anti-arthritic activity when applied to the skin of rats, Agents and Actions12, 225–231 (1982).

    PubMed  Google Scholar 

  66. P.M. May andR.A. Bulman, The present status of chelating agents in medicine. InProgress in Medicinal Chemistry, vol. 20, pp. 225–336 (EdsG.P. Ellis andG.B. West). Elsevier Science Publisher 1983.

  67. I. Sternlieb,Copper and the liver, Gastroenterology78, 1615–1628 (1980).

    PubMed  Google Scholar 

  68. M.W. Whitehouse, L. Field, R.G. Ryall andC.W. Denko,Is penicillamine a precursor drug? Scand. J. Rheumatol.4, Suppl. 8, Abstr. 183 (1975).

  69. R. Brigelius, R. Spöttl, W. Bors, E. Lengfelder, M. Saran andU. Weser,Superoxide dismutase activity of low molecular weight Cu 2+-chelates studied by pulse radiolysis, FEBS Letters47, 72–75 (1974).

    Article  PubMed  Google Scholar 

  70. R. Brigelius, H.J. Hartmann, W. Bors, M. Saran, E. Lengfelder andU. Weser,Superoxide dismutase activity of Cu(Tyr) 2 and Cu,Co-erythrocuprein, Hoppe-Seyler's Z. physiol. Chem.356, 739–745 (1975).

    PubMed  Google Scholar 

  71. M. Cutolo, S. Rovida, E. Samanta andS. Accardo, Effect of drugs on serum copper and its correlation with other humoral factors in rheumatoid arthritis. InInflammation: Mechanisms and Treatment, pp. 451–456 (EdsD.A. Willoughby andJ.P. Giroud). MTP Press Limited 1980.

  72. W.E. Smith, D.H. Brown, J. Dunlop, R. Hazelton, R.D. Sturrock andA.J. Lewis, The effect of therapeutic agents on serum copper levels and serum oxidase activities in the rat adjuvant model compared to analogous results from studies of rheumatoid arthritis in humans. InInflammation: Mechanisms and Treatment, pp. 457–463 (EdsD.A. Willoughby andJ.P. Giroud). MTP Press Limited 1980.

  73. P.E. Lipsky andM. Ziff, The mechanisms of action of gold andd-penicillamine in rheumatoid arthritis. InAdvances in Inflammation Research, vol. 3, pp. 219–235 (EdsM. Ziff, G.P. Velo andS. Gorini). Raven Press, New York 1982.

    Google Scholar 

  74. G. Arena, G. Kavu andD.R. Williams,Metalligand complexes involved in rheumatoid arthritis. V. Formation constants for calcium(II)-, magnesium(II)-and copper(II)-salicylate and acetylsalicylate interactions, J. inorg. nucl. Chem.40, 1221–1226 (1978).

    Article  Google Scholar 

  75. G.E. Jackson, P.M. May andD.R. Williams,Metal-ligand complexes involved in rheumatoid arthritis. VI. Computer models simulating the low molecular weight complexes present in blood plasma for normal and arthritic individuals, J. inorg. nucl. Chem.40, 1227–1234 (1978).

    Article  Google Scholar 

  76. C. Brevard andP. Granger,Handbook of High Resolution Multinuclear NMR. John Wiley and Sons, New York 1981.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, University of Verona, Verona, Italy

    Roberto Milanino, Anita Conforti, Luigina Franco, Mauro Marrella & Giampaolo Velo

Authors
  1. Roberto Milanino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita Conforti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luigina Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mauro Marrella
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giampaolo Velo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milanino, R., Conforti, A., Franco, L. et al. Review: Copper and inflammation — a possible rationale for the pharmalogical manipulation of inflammatory discorders. Agents and Actions 16, 504–513 (1985). https://doi.org/10.1007/BF01983655

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01983655

Keywords

Search

Navigation